'Nonalcoholic fatty liver disease' diaporamas de présentation

IN THE NAME OF GOD

IN THE NAME OF GOD. KAMRAN YAGHOBPOUR. The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases. AGENDA. Definition The importance of taking care about NAFLD in diabetic patients

1.26k views • 126 slides

Cirrhosis

Cirrhosis. Liver Physiology. Liver Structure. Largest gland in the body:. Liver Structure. There are two main lobes: - The right and left lobe. Liver Structure. The liver gets blood from the hepatic artery and the portal vein.

1.42k views • 92 slides

Nonalcoholic Fatty Liver Disease

1.65k views • 90 slides

Epidemiology of the Metabolic Syndrome in the USA

Epidemiology of the Metabolic Syndrome in the USA. Epidemiology Evaluates a Disease. Incidence ? Prevalence Distribution Control ?. Epidemiology of the Metabolic Syndrome. What is It ?. Why are its Limitations ?. Why is It Important ? What is its Prevalence ?

814 views • 60 slides

Outpatient Management of Chronic Liver Disease

Outpatient Management of Chronic Liver Disease. Quinn Jackson MD Val Carrejo MD October 9, 2019. Objectives. Know how to address abnormal LFTs in the outpatient setting Understand the impact of NASH and how to treat it

1.26k views • 35 slides

Non-alcoholic steatohepatitis

Chapter 11. Non-alcoholic steatohepatitis. Wen-Ying, Chen 2006, 10. Definition of nonalcoholic fatty liver disease.

384 views • 35 slides

Atherosclerosis is the liver disease

First M oscow Medical University Chair of cardiology department of the clinic of the Internal Medicine. Atherosclerosis is the liver disease. Prof. O. Drapkina PACE Moscow 17.10.14. Mr. Lipoprotein.

352 views • 34 slides

N on a lcoholic F atty L iver D isease (NAFLD): Where are we today?

1.55k views • 32 slides

Bioactive compounds of Brazilian Regional fruits for treatment of metabolic diseases

467 views • 31 slides

NAFLD

NAFLD. Dr Allister J Grant Consultant Hepatologist. How common is NAFLD?. The most common cause of abnormal liver function tests in the United States. Estimated 30.1 million with NAFLD and 8.6 million with NASH Affects 10-24% of the population 58-74% of the obese population

1.13k views • 31 slides

Fatty liver and Cardiovascular Disease

Fatty liver and Cardiovascular Disease. Seyed Moayed Alavian M.D. Professor of Gastroenterology and Hepatology Editor-in-chief of Hepatitis Monthly E mail: editor@hepatmon.com. 3rd International Congress of Preventive Cardiology- Shiraz Grand Hotel, October 3-5, 2014. Importance.

438 views • 30 slides

LIVER CIRRHOSIS

LIVER CIRRHOSIS. DEFINITION : pathological condition with the development of fibrosis to the point that there is architectural distorsion with formation of regenerative nodules. CAUSES : Alcoholism Chronic viral hepatitis (Hepatitis B, Hepatitis C) Autoimmune hepatitis

1.3k views • 27 slides

LIVER CIRRHOSIS

LIVER CIRRHOSIS. DEFINITION : pathological condition with the development of fibrosis to the point that there is architectural distorsion with formation of regenerative nodules. CAUSES : Alcoholism Chronic viral hepatitis (Hepatitis B, Hepatitis C) Autoimmune hepatitis

398 views • 27 slides

DRUG,TOXIC AND METABOLIC DISORDERS

DRUG,TOXIC AND METABOLIC DISORDERS. DRUGS AND THE LIVER. Summary of types of drug-induced liver disease. Necrosis - zonal (usually zone 3), diffuse, massive.

362 views • 21 slides

Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease. s_khalilzadeh. A Novel Cardiometabolic Risk Factor for Type 2 Diabetes. NAFLD and T2DM. NAFLD is closely associated with features of the metabolic syndrome and is regarded as the hepatic manifestation

910 views • 20 slides

INCIDENTAL FINDINGS

369 views • 9 slides

Nonalcoholic fatty liver: Causes, Symptoms, Daignosis, Prevention and Treatment

Nonalcoholic fatty liver disease is a condition in which the liver stores excess fat but is not secondary to alcohol, a virus, drugs, metabolic disorders, syndromes and other factors that may affect the liver’s ability to metabolize or export fat.

241 views • 8 slides

Nonalcoholic Steatohepatitis Treatment Market Report Explored in Latest Research to 2026

The global nonalcoholic steatohepatitis treatment market size was valued at US$ 1,119.9 million in 2017 and is expected to witness a CAGR of 42.7% over the forecast period (2018 u2013 2026).

41 views • 4 slides

Understanding obesity and ways to keep it under control

Take benefits of miraculous treatment and decrease your weight fastly. There are some amazing Ayurvedic hospitals in Jaipur, Jodhpur, Delhi and other parts of the country as well that provide best in class obesity treatment. For more visit: http://arogyampanchakarma.in/obesity/

36 views • 3 slides